|
Post by jckrdu on Jul 14, 2014 15:53:34 GMT
|
|
|
Post by jckrdu on Jul 14, 2014 16:03:16 GMT
Not sure why the full link above to the ADXS thread on Google isn't posting, but if you simply copy the entire address above and post it into your browser, the old ADXS thread on Google will appear.
|
|
|
Post by zangtum! on Jul 14, 2014 16:39:44 GMT
"Not sure why the full link above to the ADXS thread on Google isn't posting, but if you simply copy the entire address above and post it into your browser, the old ADXS thread on Google will appear." jckdru, I think when one adds a link to a post, one has to highlight it and select the link button (little globe w/ paper, 8th from right), and then "create a link". Well, maybe not - just tried it and it's stlll truncated??? Oh well I tried.
|
|
|
Post by JHam on Jul 14, 2014 16:50:17 GMT
"Not sure why the full link above to the ADXS thread on Google isn't posting, but if you simply copy the entire address above and post it into your browser, the old ADXS thread on Google will appear." jckdru, I think when one adds a link to a post, one has to highlight it and select the link button (little globe w/ paper, 8th from right), and then "create a link". Well, maybe not - just tried it and it's stlll truncated??? Oh well I tried. Yeah, usually just posting a link will work without going through the hyperlink process which you've described. For some reason it looks like it is putting a space between the "!" and the "#" in the link and therefore separating it. Not sure how to fix it...tradeup?
|
|
|
Post by jckrdu on Jul 14, 2014 16:50:57 GMT
Zangtum - I'm running an older version of XP, and have some javascript errors so I'm not seeing those options. I'm upgrading my laptop in the next few days so will check it again then. Thanks.
|
|
|
Post by RLC on Jul 14, 2014 17:00:12 GMT
Yeah, usually just posting a link will work without going through the hyperlink process which you've described. For some reason it looks like it is putting a space between the "!" and the "#" in the link and therefore separating it. Not sure how to fix it...tradeup? Maybe try replacing the space with an underscore ("_")... ? Nvm... I just looked at the URL on the Google page and there's no underscore. I was thinking that maybe their was an underscore in the link and this site read it as a space when pasted. I know this has happened to me in the past on other sites.
|
|
|
Post by imz72 on Jul 14, 2014 17:04:45 GMT
|
|
|
Post by jckrdu on Jul 15, 2014 14:13:35 GMT
Gap in ADXS chart between $2.80 to $2.85 is being filled. As discussed on Google, the risk of that gap filling was out there given management's share grab.
I added a little more at $2.82, and will continue to add on dips.
Note: There's another very small gap in the chart from $2.55 to $2.57. I'm going to keep some funds available in case ADXS makes another move lower to fill that small gap before the prostate IND is announced.
|
|
|
Post by natureeguy on Jul 15, 2014 14:47:50 GMT
Thanks for the update Jck. I've been adding as well. I can't help to think we'll see a pr soon and a blog from the CEO. I also think we'll see some preclinical reports soon...just a wild hunch.
|
|
|
Post by rayden on Jul 18, 2014 13:43:59 GMT
|
|
|
Post by jckrdu on Jul 18, 2014 13:51:26 GMT
Hey Rayden - IMO, that was filed so ADXS doesn't have to disclose the amount of the milestone payments for the licensing deals they recently executed with Biocon and Global Biopharma. Advaxis is working to close some additional partnerships for HPV Phase 3 in the US, PD-1 combo-therapy, prostate and breast cancer trials. IMO, they don't want the potential partners for those possible deals to know the milestone payments of the prior executed deals.
|
|
|
Post by rayden on Jul 18, 2014 15:32:27 GMT
Hey Rayden - IMO, that was filed so ADXS doesn't have to disclose the amount of the milestone payments for the licensing deals they recently executed with Biocon and Global Biopharma. Advaxis is working to close some additional partnerships for HPV Phase 3 in the US, PD-1 combo-therapy, prostate and breast cancer trials. IMO, they don't want the potential partners for those possible deals to know the milestone payments of the prior executed deals. Hey jckrdu, Yeah, I was thinking the same thing. There is something up with ADXS - and I'm betting it's something positive in the near future. The $3 raise, the fact that some members reported getting calls from ADXS, urging them to vote in favor of the Proxy - they are loading up for something.
|
|
|
Post by jckrdu on Jul 18, 2014 16:22:25 GMT
Bought more at $2.62. I'll continue to average down if it drops more.
|
|
|
Post by lcd on Jul 18, 2014 17:06:22 GMT
That last gap almost filled earlier today. See if it does before close. Hope this one gets some news soon.
|
|
|
Post by natureeguy on Jul 29, 2014 12:27:52 GMT
Interesting news today. Good to see some things going on behind the scenes.
|
|
|
Post by jckrdu on Jul 29, 2014 15:48:42 GMT
That last gap almost filled earlier today. See if it does before close. Hope this one gets some news soon. Gap between $2.82 and $2.85 did fill a few days ago. Remaining gaps are today's gap-up between $2.86 and $2.90, and one from weeks ago from $2.70 to $2.73. Tiny gap from $2.55 to $2.57 as well. I had to sell some ADXS today when my next buy price on ACTC of .067 hit.
|
|
|
Post by natureeguy on Jul 29, 2014 16:01:42 GMT
Hi Jck,
Since July 18ths low of 2.65 the sp has crept up about 10%. Ok, not earth shaking, but I am hoping this is the beginning of a nice, long climb. I wonder if our new CFO had anything to do with restructuring of deal. Just speculating but I can't help to think there will be some significant news in the coming weeks. Things in India have been quiet.
|
|
|
Post by jckrdu on Jul 29, 2014 16:33:25 GMT
Hi Jck, Since July 18ths low of 2.65 the sp has crept up about 10%. Ok, not earth shaking, but I am hoping this is the beginning of a nice, long climb. I wonder if our new CFO had anything to do with restructuring of deal. Just speculating but I can't help to think there will be some significant news in the coming weeks. Things in India have been quiet. Agree this is near the bottom.... hopefully an uptrend continues. I sold a bunch of ADXS to buy more ACTC on the recent move down. Will look to re-establish a position in ADXS after ACTC recovers. Potential ADXS catalysts include: 1) News on the "end of Phase 2 meeting" with the FDA on how the HPV trials will move forward in Phase 3 in the US, 2) partnership(s) sometime before the end of 2014 (HPV Phase 3 in US, prostate, breast, and PD-1 combination deal), and 3) approval to commercialize HPV in India (via Biocon deal) after Phase 2 results. Potential ADXS risks include: 1) if HPV Phase 3 is not approved in US (based on Phase 2 results in India) until ADXS does more testing required by the FDA, and 2) if HPV is not approved for commercialization in India based on Phase 2 results - in that case ADXS would need to conduct and fund a Phase 3 HPV trial in India. While the risks are real, I believe at least 1 of the potential catalysts will hit before any risks manifest... if they do at all.
|
|
|
Post by natureeguy on Jul 29, 2014 16:58:44 GMT
Great thoughts. Just curiious,,,,, do you read anything into the "delay" or missed milestone of the IND? Any chance it's tied into something?
|
|
|
Post by jckrdu on Jul 29, 2014 17:10:49 GMT
Great thoughts. Just curiious,,,,, do you read anything into the "delay" or missed milestone of the IND? Any chance it's tied into something? Not sure on that Nature.... Could just be taking longer to get the prostate IND prepared and submitted. On the otherhand... ADXS originally said the plan was to take prostate into Phase 1 themselves to prove safety and get some initial efficacy information before partnering. But, after those comments were made (last business update meeting), Auduro announced their $365 million pre-clinical partnership with J&J, so that may have changed things. ADXS may now know what pharma is willing to pay at the preclinical stage for a listeria based therapy, and may be shopping the prostate IND to get a deal signed now.
|
|